← Back to Search

Quality of Life Interventions for Colon Cancer

Led By Kevin D Cassel, Dr. PH
Research Sponsored by University of Hawaii
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 3 months
Awards & highlights


This trial is testing a way to provide information to patients and caregivers about colon cancer that may help alleviate anxiety and improve communication with the medical team. There is no impact on cancer care that participants receive from their provider.

Who is the study for?
This trial is for adult colon cancer patients and their caregivers in Honolulu County. Patients must be newly diagnosed with stage II-III colon cancer, within 60 days post-surgery, and able to understand and write English. Caregivers can be family or someone the patient identifies as a caregiver.Check my eligibility
What is being tested?
The study provides educational resources about colon cancer via tablets to improve quality of life for patients and caregivers. It includes weekly check-ins from the study team, use of information provided on tablets, and completing surveys assessing its impact.See study design
What are the potential side effects?
There are no medical side effects since this isn't a drug trial; however, there may be a slight burden due to time spent responding to survey questions.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Perception of Care Coordination Caregiver
Perception of Care Coordination Participant
Quality of Life Scores

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group AExperimental Treatment1 Intervention
Ted Talks/Educational videos
Group II: Group 1Experimental Treatment1 Intervention
Supportive Care Materials and Resources

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for colon cancer include surgery, chemotherapy, targeted therapy, and immunotherapy. Surgery removes the tumor, which is essential for localized cancer. Chemotherapy kills rapidly dividing cancer cells, reducing tumor size and preventing spread. Targeted therapy focuses on specific molecular targets, minimizing damage to normal cells. Immunotherapy enhances the immune system's ability to recognize and destroy cancer cells. Understanding these mechanisms helps patients grasp how treatments work, the rationale behind their treatment plan, and potential side effects, improving their engagement and adherence to therapy.
Personalized nutrition intervention improves nutritional status and quality of life of colorectal cancer survivors in the community: A randomized controlled trial.Comparative effectiveness of chemopreventive interventions for colorectal cancer: protocol for a systematic review and network meta-analysis of randomised controlled trials.Colorectal cancer: prevention and management of metastatic disease.

Find a Location

Who is running the clinical trial?

University of HawaiiLead Sponsor
116 Previous Clinical Trials
54,837 Total Patients Enrolled
Alliance for Clinical Trials in OncologyOTHER
512 Previous Clinical Trials
217,506 Total Patients Enrolled
Kevin D Cassel, Dr. PHPrincipal InvestigatorUniversity of Hawaii Cancer Research Center

Media Library

Quality of Life Supportive Resources Clinical Trial Eligibility Overview. Trial Name: NCT04713007 — N/A
Colon Cancer Research Study Groups: Group A, Group 1
Colon Cancer Clinical Trial 2023: Quality of Life Supportive Resources Highlights & Side Effects. Trial Name: NCT04713007 — N/A
Quality of Life Supportive Resources 2023 Treatment Timeline for Medical Study. Trial Name: NCT04713007 — N/A
~17 spots leftby Feb 2025